Vera Therapeutics Inc (VERA)
41.38
-0.56
(-1.34%)
USD |
NASDAQ |
May 17, 16:00
41.38
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Shareholders Equity (Quarterly): 353.54M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 353.54M |
| December 31, 2023 | 101.68M |
| September 30, 2023 | 123.71M |
| June 30, 2023 | 140.52M |
| March 31, 2023 | 157.71M |
| December 31, 2022 | 76.91M |
| September 30, 2022 | 105.72M |
| Date | Value |
|---|---|
| June 30, 2022 | 121.50M |
| March 31, 2022 | 134.42M |
| December 31, 2021 | 69.59M |
| September 30, 2021 | 85.48M |
| June 30, 2021 | 92.16M |
| March 31, 2021 | -93.32M |
| December 31, 2020 | -89.35M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-93.32M
Minimum
Mar 2021
353.54M
Maximum
Mar 2024
98.59M
Average
103.70M
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 18.55B |
| Alpine Immune Sciences Inc | 332.70M |
| Fate Therapeutics Inc | 426.12M |
| Mersana Therapeutics Inc | 27.98M |
| Equillium Inc | 21.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 419.36M |
| Total Liabilities (Quarterly) | 65.81M |